↓ Skip to main content

TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway

Overview of attention for article published in Journal of Neuro-Oncology, October 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway
Published in
Journal of Neuro-Oncology, October 2019
DOI 10.1007/s11060-019-03301-0
Pubmed ID
Authors

Xia Zhou, Yadong Yang, Pengcheng Ma, Na Wang, Dong Yang, Qiu Tu, Bin Sun, Tingxiu Xiang, Xudong Zhao, Zongliu Hou, Xiangdong Fang

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2019.
All research outputs
#10,986,230
of 13,845,249 outputs
Outputs from Journal of Neuro-Oncology
#1,374
of 2,084 outputs
Outputs of similar age
#164,511
of 229,122 outputs
Outputs of similar age from Journal of Neuro-Oncology
#63
of 68 outputs
Altmetric has tracked 13,845,249 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,084 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,122 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.